NHS preparing to offer ‘game-changing’ cancer treatment
NHS preparing to offer ‘game-changing’ cancer treatment
Pediatric brainstem cancer eradicated in mice using CAR-T treatment
Engineered human immune cells can vanquish a deadly pediatric brain tumor in a mouse model, a study from the Stanford University School of Medicine has demonstrated.
GE launching its viral vector factory-in-a-box prefab KUBio labs
GE, best known for making lightbulbs and jet engines, is launching its KUBio factory-in-a-box prefab line of drug manufacturing units that will help biopharma companies produce viral vector-based vaccines, oncolytic viruses, and gene and cell therapies.
Human chimeric cells restore crucial protein in Duchenne muscular dystrophy
Cells made by fusing a normal human muscle cell with a muscle cell from a person with Duchenne muscular dystrophy —a rare but fatal form of muscular dystrophy—were able to significantly improve muscle function when implanted into the muscles of a mouse model of the disease. The findings are reported by researchers from the University of Illinois at Chicago in the Stem Cell Review and Reports.
Researchers grow capillaries with a neural organoid
A team of researchers at UC Davis has succeeded in growing capillaries on and into a neural organoid. In their paper published in the journal NeuroReport, the group describes how they grew capillaries with the organoid and their hopes that such research will one day lead to therapies for treating brain damage in people.
CAR T-Cell Therapy Starts to Enter MCL Space
Relapsed/refractory mantle cell lymphoma (MCL) is an aggressive disease that could benefit from the addition of chimeric antigen receptor (CAR) T-cell therapy. The ongoing ZUMA-2 trial is investigating the use of the anti-CD19 CAR T-cell product axicabtagene ciloleucel (axi-cel; Yescarta) in patients with relapsed/refractory MCL (NCT02601313).
Vitamin A derivative selectively kills liver cancer stem cells
Acyclic retinoid, an artificial compound derived from vitamin A, has been found to prevent the recurrence of hepatocellular carcinoma (HCC), the most common form of liver cancer. Now, in research published in Proceedings of the National Academy of Sciences, scientists have discovered that the compound targets one class of cancer stem cells, preventing them from giving rise to new tumors.
CRISPR used to edit DNA outside of the cell
Scientists at have developed a breakthrough CRISPR gene-editing tool, that could allow researchers to take fragments of DNA extracted from human cells, put them into a test tube, and quickly and precisely engineer multiple changes to the genetic code.
How ninja polymers are fighting killer superbugs
In Ridley Scotts seminal blockbuster Blade Runner, humanity has harnessed bio-engineering to create a race of replicants that look, act and sound human - but are made entirely from synthetic material.
CAR T Cell Therapy Market 2018 Analysis, Size, Share, Facts and Figures with Products Overview, Services and Forecast 2025
Market Research Report on “Global CAR T Cell Therapy Market-Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017-2025” is provided by Orbis Research. Get Custom Research on Requirement.
